Sequential preoperative hepatic vein embolization after portal vein embolization for extended left hepatectomy in colorectal liver metastases
© Munene et al.; licensee BioMed Central Ltd. 2013
Received: 4 May 2010
Accepted: 2 June 2013
Published: 11 June 2013
The role of portal vein embolization to increase future liver remnant (FLR) is well-established in the treatment of colorectal liver metastases. However, the role of hepatic vein embolization is unclear.
A patient with colorectal liver metastases received neoadjuvant chemotherapy prior to attempted resection. At the time of resection his tumor appeared to invade the left and middle hepatic vein, requiring an extended left hepatectomy including segments five and eight. Post-operatively, he underwent sequential left portal vein embolization followed by left hepatic vein embolization and finally, middle hepatic vein embolization. Hepatic vein embolization was performed to increase the FLR as well as to allow collateral drainage of the FLR to develop. A left trisectionectomy was then performed and no evidence of postoperative liver congestion or morbidity was found.
Sequential portal vein embolization and hepatic vein embolization for extended left hepatectomy may be considered to increase FLR and may prevent right hepatic congestion after sacrificing the middle vein.
KeywordsColorectal liver metastases Hepatic vein embolization Hepatectomy
Curative hepatic resection is the most effective treatment of colorectal liver metastases. However, a large number of patients present with disease deemed to be unresectable. A multimodal approach which includes neoadjuvant chemotherapy and/or portal vein embolization has increased the resectability rates of patients with colorectal liver metastases . Recently, hepatic vein embolization has been utilized to increase the resectability of patients with hepatobiliary malignancies to enable safe resection [2, 3]. Both portal vein embolization and hepatic vein embolization have been shown to increase the future liver remnant. In addition to increasing future liver remnant (FLR), hepatic vein embolization may also reduce hepatic venous congestion by allowing collaterals to develop prior to resection. This report describes a case of preoperative sequential portal vein embolization followed by left and middle hepatic vein embolization for colorectal liver metastases.
A 66 year-old male received a computed tomography (CT) scan of the abdomen one year after resection of a rectal cancer. His rectal cancer had been treated with low anterior resection and neoadjuvant chemotherapy, and pathology demonstrated a T3N1M0, moderately differentiated adenocarcinoma. He was referred to the hepatobiliary service for consultation. At presentation, he was asymptomatic. His past medical history was significant for hypertension. His only prior surgical procedure was low anterior resection for rectal cancer. On examination, he did not appear jaundiced; his abdominal examination was unremarkable and laboratory investigations were normal. His CT scan showed a single metastatic deposit in segment one of the liver. A positron emission tomography – computed tomography (PET/CT) scan was consistent with the CT with no extrahepatic disease found. At our institution, decisions regarding pre-surgery chemotherapy are made on a case-by-case basis. When the wait for surgery is likely to be beyond four weeks, usually patients will be offered chemotherapy. In this case, response to the various interventional radiology procedures was well beyond four weeks and for this reason chemotherapy was offered. A referral was made to medical oncologists for neoadjuvant chemotherapy and the patient received six cycles of FOLFOX. A postchemotherapy CT scan showed stable disease. Liver resection was attempted four weeks after the completion of his chemotherapy. A bilateral subcostal incision was made. After liver mobilization, it appeared that the tumor was larger than initially anticipated and had invaded past the middle hepatic vein and extended to the right of the middle vein, requiring a left trisectionectomy.
This is the first case of sequential portal vein embolization and combined left and middle hepatic vein embolization reported in the literature. Currently, the mortality associated with liver resection ranges from 0 to 5% with a morbidity ranging from 10 to 20% [4, 5]. The morbidity and mortality of extended left hepatectomy is higher than that of major resections with a reported mortality of 0% to 11.9 % and morbidity of 53% . The most common cause of mortality is abdominal sepsis and postresectional liver failure secondary to insufficient FLR. Consequently, different techniques have been used to increase FLR. In addition to ensuring an adequate FLR, the risk of postoperative hepatic congestion in our patient was significant given the patient’s right-dominant middle hepatic vein.
Portal vein embolization (PVE) has been shown to increase FLR between 7% to 27% of the total liver volume (TLV) or 20 to 46% beyond pre-PVE FLR two to eight weeks after PVE, and is therefore used to increase FLR in patients deemed to have a small remnant liver [1, 4, 7]. PVE has been shown to increase resectability rate in up to 7% of patients with a benefit in postoperative outcomes. The sufficient FLR required in a normal liver is > 20% of the total liver volume; in patients with impaired liver function this is believed to be > 40% .
Chemotherapy has been associated with increased risk of liver injury: fluorouracil (5-FU) has been associated with steatosis; oxaliplatin-based regimens have been associated with vascular injuries; and irinotecan-based regimens have been associated with steatosis and steatohepatitis. The exact consequence of these histopathological lesions is unclear but patients with steatohepatitis have been shown to have higher incidences of posthepatectomy complications . The regenerative ability of chemotherapy injured livers has been shown to be unimpaired following portal vein embolization .
PVE has been utilized in extended right hepatectomies, has been found to be safe and can increase the remnant liver . In this case, the patient’s liver appeared to be grossly steatotic and the ideal FLR required for a safe resection was unclear. In this case, on volumetric analyses the posterior section appeared to be < 25% of total liver volume and the left portal vein was embolized with an increase in FLR to 30%.
PVE is not without risks; the greatest concern is for rapid tumor growth due to the increased production of growth stimulants, presumably in response to PVE. Animal models and one human study in humans have produced inconclusive data . After PVE, careful monitoring of tumor response is warranted, and some have recommended concurrent chemotherapy after PVE to control for the deleterious effects PVE may have on tumor growth [8, 12].
The role of hepatic vein embolization in improving resectability rates and the safety of extended resections of patients with FLR < 20% after PVE is unclear. Hwang et al. recently showed, in a study of 12 patients who underwent hepatic resection for hepatobiliary malignancy, that sequential right hepatic vein embolization after right PVE had an incremental effect on the FLR. Immunohistochemistry showed increased apopotosis after hepatic vein embolization following PVE, suggesting that hepatic vein embolization induced a more severe injury. Hepatic vein embolization was shown to be safe and did not appear to increase blood liver enzymes any more than did portal vein embolization . The study only included patients who underwent right-sided resections and therefore, only patients who underwent right hepatic vein embolization .
This report is the first to document the use of left and middle vein embolization in an attempt to increase FLR. In this case, after PVE, the FLR increased to > 30%, but after hepatic vein embolization no additional increase was documented on volumetric analysis. There was a transient increase in liver enzymes after portal vein and hepatic vein embolization which normalized prior to the curative resection, and no complications were associated with either procedure.
Venous congestion associated with sacrificing the middle hepatic vein has been associated with physiological impairment, functional small-for-size syndrome, loss of the graft and death of living liver transplant donors [13–18]. Management of the middle hepatic vein remains a controversial topic, especially for right graft living donor liver transplants. Using CT volumetric analysis, many centers have devised algorithms that attempt to predict the risk of congestion associated with middle hepatic vein harvest [13, 18, 19]. Some centers have advocated the utilization of vein reconstruction to prevent congestion . Congestion leads to necrosis of the marginal zones of the remnant liver and may lead to increased biliary complications and potentially infection. Scatton et al. showed that hepatic congestion was associated with impaired liver function and volumetric regeneration. Even though the clinical consequences of congestion were moderate in the healthy donor population, this effect may be severe in patients after extended resection with small remnants and diseased livers .
The role of hepatic congestion in decreasing the remnant liver and increasing morbidity and mortality after extended resections has been documented in a number of studies [21–24]. Lang et al. found that, when using computer-assisted risk analysis to plan for major hepatectomies, the amount of devascularized liver tissue was greater than 20% and up to 43% of that anticipated by 2D CT. Most of the reduction in vascularized liver tissue resulted from hepatic congestion. In particular, for patients who were to undergo extended left hepatectomies, a large portion of segment six drained into the middle hepatic vein. Based on their preoperative findings, the surgical team involved planned vein reconstructions for these patients after intraoperative confirmation of hepatic congestion.
Multiple studies have reported on their experience of venous reconstruction to prevent hepatic congestion, with good outcomes. Venous reconstruction increases the complexity of the operation and is associated with complications . We hypothesize that an alternative to venous reconstruction could be preoperative hepatic vein embolization to increase collateralization gradually so as to decrease early hepatic congestion. Our patient appeared to be at high risk of congestion given his large accessory vein draining from his right liver into the middle hepatic vein. Using an animal model, Ku et al. showed that preoperative hepatic vein embolization resulted in increased collateralization of interlobar and interlobular collaterals in two weeks. In the only published case report to document an increase in venous drainage after hepatic vein embolization, a right hepatic vein embolization was done to enable an inferior right hepatic vein-preserving left hepatic trisectionectomy with combined resection of the distal right hepatic vein without reconstruction. Preoperative hepatic vein embolization increased drainage via the inferior right hepatic vein, allowing a safe resection without congestion .
Preoperative studies can now identify patients with middle hepatic vein-dominant right livers, and a study to evaluate the benefits of preoperative hepatic embolization prior to resection in these groups of patients is warranted because it may decrease postoperative hepatic congestion, and may preclude the need for venous reconstruction. Hepatic vein embolization is associated with the risk of dislodgement of the embolic material because the hepatic vein is retrograde and the vein is larger distally than proximally.
In conclusion, we have presented a case where a combination of neoadjuvant chemotherapy, sequential preoperative portal vein embolization and hepatic embolization enabled a safe left trisectionectomy with excellent outcome. The role of hepatic vein embolization to increase future liver remnant and to decrease postoperative hepatic congestion in well-selected patients warrants further study.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the editor-in-chief of this journal.
Estimated blood loss
Future liver remnant
International normalized ratio
Positron emission tomography – computed tomography
Portal vein emolization
Total liver volume
- Abulkhir A, Limongelli P, Healey AJ: Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008, 247 (1): 49-57. 10.1097/SLA.0b013e31815f6e5b.View ArticlePubMed
- Hwang S, Lee SG, Ko GY: Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg. 2009, 249 (4): 608-616. 10.1097/SLA.0b013e31819ecc5c.View ArticlePubMed
- Ko GY, Hwang S, Sung KB: Interventional oncology: new options for interstitial treatments and intravascular approaches: right hepatic vein embolization after right portal vein embolization for inducing hypertrophy of the future liver remnant. J Hepatobiliary Pancreat Surg. 2010, 17: 410-412. 10.1007/s00534-009-0235-y.View Article
- Hemming AW, Reed AI, Howard RJ: Preoperative portal vein embolization for extended hepatectomy. Ann Surg. 2003, 237 (5): 686,91-Discussion 691–3
- Kishi Y, Abdalla EK, Chun YS: Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg. 2009, 250: 540-548.PubMed
- Lang H, Sotiropoulos GC, Brokalaki EI: Left hepatic trisectionectomy for hepatobiliary malignancies. J Am Coll Surg. 2006, 203 (3): 311-321. 10.1016/j.jamcollsurg.2006.05.290.View ArticlePubMed
- Capussotti L, Muratore A, Baracchi F: Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases. Arch Surg. 2008, 143 (10): 978-982. 10.1001/archsurg.143.10.978. Discussion 982View ArticlePubMed
- Tanaka K, Kumamoto T, Matsuyama R: Influence of chemotherapy on liver regeneration induced by portal vein embolization or first hepatectomy of a staged procedure for colorectal liver metastases. J Gastrointest Surg. 2009, 10.1007/s11605-009-1073-6.
- Zorzi D, Chun YS, Madoff DC: Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann Surg Oncol. 2008, 15 (10): 2765-2772. 10.1245/s10434-008-0035-7.View ArticlePubMed
- Vauthey JN, Pawlik TM, Abdalla EK: Is extended hepatectomy for hepatobiliary malignancy justified?. Ann Surg. 2004, 239 (5): 722-30. 10.1097/01.sla.0000124385.83887.d5. Discussion 730–2PubMed CentralView ArticlePubMed
- Pamecha V, Levene A, Grillo F: Effect of portal vein embolization on the growth rate of colorectal liver metastases. Br J Cancer. 2009, 100 (4): 617-622. 10.1038/sj.bjc.6604872.PubMed CentralView ArticlePubMed
- Nafidi O, Desy D, Letourneau R: Hypertrophy of the non-embolized liver after chemotherapy. HPB (Oxford). 2009, 11 (2): 103-107. 10.1111/j.1477-2574.2009.00004.x.View Article
- Asakuma M, Fujimoto Y, Bourquain H: Graft selection algorithm based on congestion volume for adult living donor liver transplantation. Am J Transplant. 2007, 7 (7): 1788-1796. 10.1111/j.1600-6143.2007.01849.x.View ArticlePubMed
- Dirsch O, Madrahimov N, Chaudri N: Recovery of liver perfusion after focal outflow obstruction and liver resection. Transplantation. 2008, 85 (5): 748-756. 10.1097/TP.0b013e31816631f9.View ArticlePubMed
- Lee HJ, Kim KW, Mun HS: Uncommon causes of hepatic congestion in patients after living donor liver transplantation. AJR Am J Roentgenol. 2009, 193 (3): 772-780. 10.2214/AJR.08.1782.View ArticlePubMed
- Lee S, Park K, Hwang S: Anterior segment congestion of a right liver lobe graft in living donor liver transplantation and strategy to prevent congestion. J Hepatobiliary Pancreat Surg. 2003, 10 (1): 16-25.PubMed
- Mizuno S, Iida T, Yagi S: Impact of venous drainage on regeneration of the anterior segment of right living-related liver grafts. Clin Transplant. 2006, 20 (4): 509-516. 10.1111/j.1399-0012.2006.00515.x.View ArticlePubMed
- Radtke A, Sotiropoulos GC, Sgourakis G: ‘Anatomical’ versus ‘territorial’ belonging of the middle hepatic vein: virtual imaging and clinical repercussions. J Surg Res. 2011, 166 (1): 146-155. 10.1016/j.jss.2009.07.042.View ArticlePubMed
- Hwang HJ, Kim KW, Jeong WK: Right hepatic vein stenosis at anastomosis in patients after living donor liver transplantation: optimal Doppler US venous pulsatility index and CT criteria-receiver operating characteristic analysis. Radiology. 2009, 253 (2): 543-551. 10.1148/radiol.2532081858.View ArticlePubMed
- Scatton O, Plasse M, Dondero F: Impact of localized congestion related to venous deprivation after hepatectomy. Surgery. 2008, 143 (4): 483-489. 10.1016/j.surg.2007.11.002.View ArticlePubMed
- Lang H, Radtke A, Hindennach M: Impact of virtual tumor resection and computer-assisted risk analysis on operation planning and intraoperative strategy in major hepatic resection. Arch Surg. 2005, 140 (7): 629-38. 10.1001/archsurg.140.7.629. Discussion 638View ArticlePubMed
- Nagino M, Yamada T, Kamiya J: Left hepatic trisegmentectomy with right hepatic vein resection after right hepatic vein embolization. Surgery. 2003, 133 (5): 580-582. 10.1067/msy.2003.105.View ArticlePubMed
- Ozeki Y, Uchiyama T, Katayama M: Extended left hepatic trisegmentectomy with resection of main right hepatic vein and preservation of middle and inferior right hepatic veins. Surgery. 1995, 117 (6): 715-717. 10.1016/S0039-6060(95)80018-2.View ArticlePubMed
- Shindoh J, Kokudo N, Miura Y: In situ hepatic vein graft: a simple new technique for hepatic venous reconstruction. Hepatogastroenterology. 2007, 54 (78): 1748-1751.PubMed
- Hemming AW, Reed AI, Langham MR: Hepatic vein reconstruction for resection of hepatic tumors. Ann Surg. 2002, 235 (6): 850-858. 10.1097/00000658-200206000-00013.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.